Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 816.00
+8.35 (1.03%)
Jun 19, 2026, 3:30 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 16.84 billion as of June 18, 2026. Its market cap has decreased by -11.69% in one year.
Market Cap
16.84B
Enterprise Value
14.49B
Revenue
9.04B
Ranking
n/a
PE Ratio
26.20
Stock Price
816.00
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 16.84B, an increase of 89.77%. That is a compound annual growth rate of 14.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 16.84B | 1.05% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | 8.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 62.72B |
| Innova Captab | 54.34B |
| Orchid Pharma | 49.66B |
| RPG Life Sciences | 37.67B |
| Solara Active Pharma Sciences | 27.13B |
| Indoco Remedies | 21.69B |
| Beta Drugs | 20.09B |
| Sakar Healthcare | 17.88B |